Filing Details

Accession Number:
0001209191-14-004715
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-23 20:26:32
Reporting Period:
2014-01-21
Filing Date:
2014-01-23
Accepted Time:
2014-01-23 20:26:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326104 Jeffrey David Medeiros 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Evp And Cto No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-21 1,771 $5.12 119,822 No 4 M Direct
Common Stock Disposition 2014-01-21 1,771 $62.00 118,051 No 4 S Direct
Common Stock Acquisiton 2014-01-21 1,042 $14.24 119,093 No 4 M Direct
Common Stock Disposition 2014-01-21 1,042 $62.00 118,051 No 4 S Direct
Common Stock Acquisiton 2014-01-21 1,250 $35.78 119,301 No 4 M Direct
Common Stock Disposition 2014-01-21 1,250 $62.00 118,051 No 4 S Direct
Common Stock Acquisiton 2014-01-23 48,229 $5.12 166,280 No 4 M Direct
Common Stock Disposition 2014-01-23 48,229 $65.00 118,051 No 4 S Direct
Common Stock Acquisiton 2014-01-23 35,416 $14.24 153,467 No 4 M Direct
Common Stock Disposition 2014-01-23 35,416 $65.00 118,051 No 4 S Direct
Common Stock Acquisiton 2014-01-23 27,500 $35.78 145,551 No 4 M Direct
Common Stock Disposition 2014-01-23 27,500 $65.00 118,051 No 4 S Direct
Common Stock Acquisiton 2014-01-23 18,333 $35.78 136,384 No 4 M Direct
Common Stock Disposition 2014-01-23 18,333 $65.00 118,051 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-01-21 1,771 $0.00 1,771 $5.12
Common Stock Stock Option (right to buy) Disposition 2014-01-21 1,042 $0.00 1,042 $14.24
Common Stock Stock Option (right to buy) Disposition 2014-01-21 1,250 $0.00 1,250 $35.78
Common Stock Stock Option (right to buy) Disposition 2014-01-23 48,229 $0.00 48,229 $5.12
Common Stock Stock Option (right to buy) Disposition 2014-01-23 35,416 $0.00 35,416 $14.24
Common Stock Stock Option (right to buy) Disposition 2014-01-23 27,500 $0.00 27,500 $35.78
Common Stock Stock Option (right to buy) Disposition 2014-01-23 18,333 $0.00 18,333 $35.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,229 2020-01-18 No 4 M Direct
48,958 2021-02-15 No 4 M Direct
58,750 2022-02-14 No 4 M Direct
0 2020-01-18 No 4 M Direct
13,542 2021-02-15 No 4 M Direct
31,250 2022-02-14 No 4 M Direct
1,667 2022-02-14 No 4 M Direct
Footnotes
  1. Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
  2. The option was granted on 01/19/2010 for the right to buy 85,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
  3. The option was granted on 02/16/2011 for the right to buy 50,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
  4. The option was granted on 02/15/2012 for the right to buy 60,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
  5. The option was granted on 02/15/2012 for the right to buy 20,000 shares of common stock of the Issuer. Options vested pursuant to achievement of certain performance-based criteria. As of the date of this report, 1,667 shares of common stock remain subject to vesting.